(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Updated "ICH Q7 Side-by-Side Comparison" Booklet Released
In early 2025, APIC (a sector group of CEFIC) released Version 17 of the “How to do” Document – Interpretation of ICH Q7 Guide and Review Form for active pharmaceutical ingredients. Key updates were made in the chapters on Quality Management, Production Equipment, Change Control, and the Annex with Q&As linked to ICH Q7 sections.
To support understanding, the "ICH Q7 Side-by-Side Comparison" booklet has been updated. It aligns the ICH Q7 GMP requirements with APIC’s interpretations, providing clear guidance on compliance.
Participants of the ICH Q7 Training Week (30 June – 4 July 2025 in Copenhagen) will receive a free copy of the updated booklet. For full details, visit the ICH Q7 Week website.
18-06-2025
📰 Recent News
- APIC Releases Updated Nitrosamine Risk Management Guide
- Updated "ICH Q7 Side-by-Side Comparison" Booklet Released
- Swissmedic Clarifies GMP Scope for Drug Preparation vs. Manufacturing
- FDA Issues Warning to Chinese Manufacturer Over Sterility Failures
- FDA Criticises Root Cause Investigations at EU Facility
- World Health Organization releases warning on falsified medicines used for diabetes treatment and we
- FDA issues Warning Letters for Selling Products constituting Delta-8 THC
- NABH Directs HCOs to Align Facility Names with Actual Services
- EU Council Sets Stance on Pharma Reform Package
- FDA Flags CGMP Violations at Strukmyer LLC